Loading...

e-therapeutics PLC announces completion of £28.90 million fundraise

One of our clients, e-therapeutics PLC announces completion of £28.90 million fundraise.

London, UK, 3 July 2024 – e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, is pleased to announce that it has completed its £28.90 million fundraise by way of a subscription by funds managed by M&G Investment Management Limited and Richard Griffiths and his controlled undertakings, both existing shareholders of the Company. The Subscription by M&G was conditional upon clearance under the National Security and Investment Act 2021, which is now complete.

To read more, please see the full EQS here.

e-therapeutics PLC announces completion of £28.90 million fundraise

By Mason JP Jenkins Profile 04 Jul 2024